SEC Form 4 · accession 0001104659-15-076190
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanofi
10% Owner
Period of report
Nov 3, 2015
Accepted (ET)
Nov 5, 2015 · 2:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock Par value per share $ 0.0001 | Nov 3, 2015 | C | 2,318,899 | $0.00 | A | 2,318,899 | I | Via wholly owned subsidiary Aventis Inc. |
| Common stock Par value per share $ 0.0001 | Nov 3, 2015 | P | 900,000 | $10.00 | A | 3,218,899 | I | Via wholly owned subsidiary Aventis Inc. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A-1 redeemable convertible preferred stockF1 | $0.00 | Nov 3, 2015 | C | 6,666,667 | D | — | — | Common stocks | 1,814,059 | 0 | I |
| Series B redeemable convertible preferred stockF1 | $0.00 | Nov 3, 2015 | C | 1,855,288 | D | — | — | Common stocks | 504,840 | 0 | I |
Explanation of responses
- F1Conversion upon Initial Public Offering